The Shares of Fredun Pharmaceuticals Ltd have delivered 8,820% in just six years, as the share price has risen from Rs 12.5 in March 2016 to the current level of Rs 1,114 on the BSE.
Fredun Pharmaceuticals Limited has established itself as a reliable and ethical Company over the years. The company is into manufacturing dietary /herbal supplements, nutraceuticals, and other healthcare products along with Animal Healthcare products.
If an investor would have invested Rs 1 lakh in the company in March 2016, the total value of their holdings would be Rs 89.20 Lakhs today.
The shares reached an all-time high of Rs 1,428 in November this year. At that point, the total value of Rs 1 lakh would have been 1.06 Crore as the shares logged a return of 10,560%.
The Pharma company has a strong presence in India and exports its products to 40+ countries across Africa, South East Asia, CIS countries, and Latin America. It primarily exports to non/ semi-regulated markets.
In Q2FY23, the company reported a total revenue jumped 28 percent to Rs 70.32 crore from Rs 54.76 crore in the same period a year ago. In the previous quarter, their revenue stood at Rs 48.42 crore.
In the quarter under review, they reported a total net profit of Rs 3.15 Crore which increased 71 percent from Rs 1.84 crore in Q2FY22. On a sequential basis, their earnings increased from Rs 0.94 crore.
The company has a market capitalization of Rs 503 crores. The company’s promoters hold a 51.04 percent stake with zero shares pledged. In addition to that, the Bank of India holds a 1.68 percent stake.
Written by Anoushka Roy
